Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FK8LN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,663.44 by the Defense Logistics Agency (DLA) on August 7, 2025. The delivery order, which is set to be completed by August 28, 2025, covers the supply of Nexplanon 68 mg implants—a subdermal contraceptive device used in military and federal healthcare systems. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion agreement valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies.
The contract reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. As a registered woman-owned small business in the System for Award Management since 2001, the company has demonstrated consistent capability in delivering diverse pharmaceutical products to Department of Defense healthcare facilities nationwide. The DLA utilizes its underlying indefinite delivery contract vehicle to issue firm fixed-price delivery orders for specific pharmaceutical needs across military health facilities, with this particular order addressing contraceptive supply requirements for defense medical operations.
Quick answers
Who was awarded contract SPE2DB25FK8LN?
SPE2DB25FK8LN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FK8LN worth?
The government has obligated $16,663 on SPE2DB25FK8LN.
Is contract SPE2DB25FK8LN an order under another contract?
Yes. SPE2DB25FK8LN is a delivery order under SPE2DB22D9330, an indefinite delivery contract.
Was contract SPE2DB25FK8LN competed?
The extent of competition for SPE2DB25FK8LN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award